{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:11:53Z","timestamp":1792228313277,"version":"4.4.0"},"reference-count":173,"publisher":"Walter de Gruyter GmbH","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Multiple sclerosis (MS) is a chronic, progressive disease of the central nervous system that is characterised by inflammatory damage to the myelin sheath. Though often neglected, cognitive impairment is a common feature of MS that affects 43\u201370% of patients. It has a sophisticated neuroanatomic and pathophysiologic background and disturbs such vital cognitive domains as speed of information processing, memory, attention, executive functions and visual perceptual functions. In recent years there has been growing interest in neuroimaging findings with regard to cognitive impairment in MS. The possible options of managing cognitive dysfunction in MS are pharmacologic interventions, cognitive rehabilitation and exercise training; however, not enough evidence has been presented in this field. The aim of our article is to provide current knowledge on cognitive impairment in MS based on the most recent scientific results and conclusions with regard to affected cognitive domains, neuropsychological assessment, underlying mechanisms of this disturbance, neuroimaging findings and therapeutic options.<\/jats:p>","DOI":"10.1515\/revneuro-2017-0011","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T10:01:54Z","timestamp":1502186514000},"page":"845-860","source":"Crossref","is-referenced-by-count":144,"title":["Cognitive impairment in multiple sclerosis \u2013 a review of current knowledge and recent research"],"prefix":"10.1515","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9197-1117","authenticated-orcid":false,"given":"Tomasz","family":"Grzegorski","sequence":"first","affiliation":[{"name":"Department of Clinical Neuroimmunology , Chair of Neurology , Poznan University of Medical Sciences , 49 Przybyszewskiego Street , 60-355 Poznan , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Losy","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroimmunology , Chair of Neurology , Poznan University of Medical Sciences , 49 Przybyszewskiego Street , 60-355 Poznan , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2017,8,8]]},"reference":[{"key":"2024080906554937378_j_revneuro-2017-0011_ref_001_w2aab3b7b2b1b6b1ab1c11b1Aa","doi-asserted-by":"crossref","unstructured":"Adler, G. and Lembach, Y. (2015). Memory and selective attention in multiple sclerosis: cross-sectional computer-based assessment in a large outpatient sample. Eur. Arch. Psychiatry Clin. Neurosci. 265, 439\u2013443.10.1007\/s00406-015-0574-4","DOI":"10.1007\/s00406-015-0574-4"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_002_w2aab3b7b2b1b6b1ab1c11b2Aa","doi-asserted-by":"crossref","unstructured":"Amato, M.P., Goretti, B., Ghezzi, A., Lori, S., Zipoli, V., Moiola, L., Falautano, M., De Caro, M.F., Viterbo, R., Patti, F., et al. (2010). Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. Neurology 75, 1134\u20131140.10.1212\/WNL.0b013e3181f4d82120876467","DOI":"10.1212\/WNL.0b013e3181f4d821"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_003_w2aab3b7b2b1b6b1ab1c11b3Aa","doi-asserted-by":"crossref","unstructured":"Amato, M.P., Hakiki, B., Goretti, B., Rossi, F., Stromillo, M.L., Giorgio, A., Roscio, M., Ghezzi, A., Guidi, L., Bartolozzi, M.L., et al. (2012). Association of MRI metrics and cognitive impairment in radiologically isolated syndromes. Neurology 78, 309\u2013314.10.1212\/WNL.0b013e31824528c922262744","DOI":"10.1212\/WNL.0b013e31824528c9"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_004_w2aab3b7b2b1b6b1ab1c11b4Aa","doi-asserted-by":"crossref","unstructured":"Arnett, P.A., Higginson, C.I., and Randolph, J.J. (2001). Depression in multiple sclerosis: relationship to planning ability. J. Int. Neuropsychol. Soc. 7, 665\u2013674.1157558810.1017\/S1355617701766027","DOI":"10.1017\/S1355617701766027"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_005_w2aab3b7b2b1b6b1ab1c11b5Aa","doi-asserted-by":"crossref","unstructured":"Audoin, B., Au Duong, M.V., Malikova, I., Confort-Gouny, S., Ibarrola, D., Cozzone, P.J., Pelletier, J. and Ranjeva, J.P. (2006). Functional magnetic resonance imaging and cognition at the very early stage of MS. J. Neurol. Sci. 245, 87\u201391.10.1016\/j.jns.2005.08.02616631203","DOI":"10.1016\/j.jns.2005.08.026"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_006_w2aab3b7b2b1b6b1ab1c11b6Aa","doi-asserted-by":"crossref","unstructured":"Beatty, W.W. and Aupperle, R.L. (2002). Sex differences in cognitive impairment in multiple sclerosis. Clin. Neuropsychol. 16, 472\u2013480.1282205610.1076\/clin.16.4.472.13904","DOI":"10.1076\/clin.16.4.472.13904"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_007_w2aab3b7b2b1b6b1ab1c11b7Aa","unstructured":"Beatty, W.W., Goodkin, D.E., Monson, N., and Beatty, P.A. (1990). Implicit learning in patients with chronic progressive multiple sclerosis. Int. J. Clin. Neuropsychol. 12, 166\u2013172."},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_008_w2aab3b7b2b1b6b1ab1c11b8Aa","doi-asserted-by":"crossref","unstructured":"Beatty, W.W., Paul, R.H., Blanco, C.R., Hames, K.A., and Wilbanks, S.L. (1995). Attention in multiple sclerosis: correlates of impairment on the WAIS-R digit span test. Appl. Neuropsychol. 2, 139\u2013144.1631851710.1080\/09084282.1995.9645351","DOI":"10.1207\/s15324826an0203&4_6"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_009_w2aab3b7b2b1b6b1ab1c11b9Aa","doi-asserted-by":"crossref","unstructured":"Benedict, R.H. and Bobholz, J.H. (2007). Multiple sclerosis. Semin. Neurol. 27, 78\u201385.1722674410.1055\/s-2006-956758","DOI":"10.1055\/s-2006-956758"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_010_w2aab3b7b2b1b6b1ab1c11c10Aa","doi-asserted-by":"crossref","unstructured":"Benedict, R.H. and Zivadinov, R. (2011). Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat. Rev. Neurol. 7, 332\u2013342.10.1038\/nrneurol.2011.6121556031","DOI":"10.1038\/nrneurol.2011.61"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_011_w2aab3b7b2b1b6b1ab1c11c11Aa","doi-asserted-by":"crossref","unstructured":"Benedict, R.H., Fischer, J.S., Archibald, C.J., Arnett, P.A., Beatty, W.W., Bobholz, J., Chelune, G.J., Fisk, J.D., Langdon, D.W., Caruso, L., et al. (2002). Minimal neuropsychological assessment of MS patients: a consensus approach. Clin. Neuropsychol. 16, 381\u2013397.10.1076\/clin.16.3.381.1385912607150","DOI":"10.1076\/clin.16.3.381.13859"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_012_w2aab3b7b2b1b6b1ab1c11c12Aa","doi-asserted-by":"crossref","unstructured":"Benedict, R.H., Carone, D.A., and Bakshi, R. (2004). Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis. J. Neuroimaging 14(Suppl.), 36\u201345.10.1177\/1051228404266267","DOI":"10.1177\/1051228404266267"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_013_w2aab3b7b2b1b6b1ab1c11c13Aa","doi-asserted-by":"crossref","unstructured":"Benedict, R.H., Cookfair, D., Gavett, R., Gunther, M., Munschauer, F., Garg, N., and Weinstock-Guttman, B. (2006). Validity of the minimal assessment of cognitive function in multiple sclerosis. J. Int. Neuropsychol. Soc. 12, 549\u2013558.16981607","DOI":"10.1017\/S1355617706060723"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_014_w2aab3b7b2b1b6b1ab1c11c14Aa","doi-asserted-by":"crossref","unstructured":"Benedict, R.H., Amato, M.P., Boringa, J., Brochet, B., Foley, F., Fredrikson, S., Hamalainen, P., Hartung, H., Krupp, L., Penner, I., et al. (2012). Brief international cognitive assessment for MS (BICAMS): international standards for validation. BMC Neurol. 12, 55.10.1186\/1471-2377-12-5522799620","DOI":"10.1186\/1471-2377-12-55"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_015_w2aab3b7b2b1b6b1ab1c11c15Aa","doi-asserted-by":"crossref","unstructured":"Bergendal, G., Fredrikson, S., and Almkvist, O. (2007). Selective decline in information processing in subgroups of multiple sclerosis: an 8 year old longitudinal study. Eur. Neurol. 57, 193\u2013202.10.1159\/000099158","DOI":"10.1159\/000099158"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_016_w2aab3b7b2b1b6b1ab1c11c16Aa","doi-asserted-by":"crossref","unstructured":"Bergsland, N., Zivadinov, R., Dwyer, M.G., Weinstock-Guttman, B., and Benedict, R.H. (2016). Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients. Mult. Scler. 22, 1327\u20131336.10.1177\/135245851561620426541795","DOI":"10.1177\/1352458515616204"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_017_w2aab3b7b2b1b6b1ab1c11c17Aa","doi-asserted-by":"crossref","unstructured":"Bisecco, A., Stamenova, S., Caiazzo, G., d\u2019Ambrosio, A., Sacco, R., Docimo, R., Esposito, S., Cirillo, M., Esposito, F., Bonavita, S., et al. (2017). Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume. Brain Imaging Behav. (Epub ahead of print).28083844","DOI":"10.1007\/s11682-016-9667-6"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_018_w2aab3b7b2b1b6b1ab1c11c18Aa","doi-asserted-by":"crossref","unstructured":"Bodling, A.M., Denney, D.R., and Lynch, S.G. (2009). Cognitive aging in patients with multiple sclerosis: a cross-sectional analysis of speeded processing. Arch. Clin. Neuropsychol. 24, 761\u2013767.1982024610.1093\/arclin\/acp076","DOI":"10.1093\/arclin\/acp076"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_019_w2aab3b7b2b1b6b1ab1c11c19Aa","doi-asserted-by":"crossref","unstructured":"Bora, E., \u00d6zakba\u015f, S., Velakoulis, D., and Walterfang, M. (2016). Social cognition in multiple sclerosis: a meta-analysis. Neuropsychol. Rev. 26, 160\u2013172.10.1007\/s11065-016-9320-627324894","DOI":"10.1007\/s11065-016-9320-6"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_020_w2aab3b7b2b1b6b1ab1c11c20Aa","doi-asserted-by":"crossref","unstructured":"Brissart, H., Morele, E., Baumann, C., and Debouverie, M. (2012). Verbal episodic memory in 426 multiple sclerosis patients: impairment in encoding, retrieval or both? Neurol. Sci. 33, 1117\u20131123.10.1007\/s10072-011-0915-722240715","DOI":"10.1007\/s10072-011-0915-7"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_021_w2aab3b7b2b1b6b1ab1c11c21Aa","doi-asserted-by":"crossref","unstructured":"Brooks, J.B., Borela, M.C., and Fragoso, Y.D. (2011). Assessment of cognition using the Rao\u2019s Brief Repeatable Battery of Neuropsychological Tests on a group of Brazilian patients with multiple sclerosis. Arq. Neuropsiquiatr. 69, 887\u2013891.2229787310.1590\/S0004-282X2011000700007","DOI":"10.1590\/S0004-282X2011000700007"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_022_w2aab3b7b2b1b6b1ab1c11c22Aa","doi-asserted-by":"crossref","unstructured":"Bruce, J.M., Bruce, A.S., and Arnett, P.A. (2007). Mild visual acuity disturbances are associated with performance on tests of complex visual attention in MS. J. Int. Neuropsychol. Soc. 13, 544\u2013548.17445304","DOI":"10.1017\/S1355617707070658"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_023_w2aab3b7b2b1b6b1ab1c11c23Aa","doi-asserted-by":"crossref","unstructured":"Bunyan, R.F., Popescu, B.F., Carter, J.L., Caselli, R.J., Parisi, J.E., and Lucchinetti, C.F. (2011). Childhood-onset multiple sclerosis with progressive dementia and pathological cortical demyelination. Arch. Neurol. 68, 525\u2013528.10.1001\/archneurol.2011.5021482934","DOI":"10.1001\/archneurol.2011.50"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_024_w2aab3b7b2b1b6b1ab1c11c24Aa","doi-asserted-by":"crossref","unstructured":"Caine, E.D., Bamford, K.A., Schiffer, R.B., Shoulson, I., and Levy, S. (1986). A controlled neuropsychological comparison of Huntington\u2019s disease and multiple sclerosis. Arch. Neurol. 43, 249\u2013254.10.1001\/archneur.1986.005200300390092936324","DOI":"10.1001\/archneur.1986.00520030039009"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_025_w2aab3b7b2b1b6b1ab1c11c25Aa","doi-asserted-by":"crossref","unstructured":"Calabrese, M., Agosta, F., Rinaldi, F., Mattisi, I., Grossi, P., Favaretto, A., Atzori, M., Bernardi, V., Barachino, L., Rinaldi, L., et al. (2009). Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch. Neurol. 66, 1144\u20131150.19752305","DOI":"10.1001\/archneurol.2009.174"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_026_w2aab3b7b2b1b6b1ab1c11c26Aa","doi-asserted-by":"crossref","unstructured":"Calabresi, P.A., Radue, E.W., Goodin, D., Jeffery, D., Rammohan, K.W., Reder, A.T., Vollmer, T., Agius, M.A., Kappos, L., Stites, T., et al. (2014). Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Neurol. 13, 545\u2013556.10.1016\/S1474-4422(14)70049-3","DOI":"10.1016\/S1474-4422(14)70049-3"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_027_w2aab3b7b2b1b6b1ab1c11c27Aa","doi-asserted-by":"crossref","unstructured":"Caligiuri, M.E., Barone, S., Cherubini, A., Augimeri, A., Chiriaco, C., Trotta, M., Granata, A., Filippelli, E., Perrotta, P., Valentino, P., et al. (2014). The relationship between regional microstructural abnormalities of the corpus callosum and physical and cognitive disability in relapsing-remitting multiple sclerosis. Neuroimage Clin. 7, 28\u201333.25610764","DOI":"10.1016\/j.nicl.2014.11.008"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_028_w2aab3b7b2b1b6b1ab1c11c28Aa","doi-asserted-by":"crossref","unstructured":"Carmona, O., Masuet, C., Santiago, O., Al\u00eda, P., Moral, E., Alonso-Magdalena, L., Casado, V., and Arbizu, T. (2011). Multiple sclerosis and cognitive decline: is ApoE-4 a surrogate marker? Acta Neurol. Scand. 124, 258\u2013263.10.1111\/j.1600-0404.2010.01473.x21208197","DOI":"10.1111\/j.1600-0404.2010.01473.x"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_029_w2aab3b7b2b1b6b1ab1c11c29Aa","unstructured":"Charcot, J.M. (1877). Lectures on the Diseases on the Nervous System Delivered at La Salpetri\u00e8re (London: New Sydenham Society)."},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_030_w2aab3b7b2b1b6b1ab1c11c30Aa","doi-asserted-by":"crossref","unstructured":"Chenet, A., Gosseaume, A., Wiertlewski, S., and Perrouin-Verbe, B. (2016). Efficacity of exercise training on multiple sclerosis patients with cognitive impairments. Ann. Phys. Rehabil. Med. 59(Suppl.), e42.10.1016\/j.rehab.2016.07.097","DOI":"10.1016\/j.rehab.2016.07.097"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_031_w2aab3b7b2b1b6b1ab1c11c31Aa","doi-asserted-by":"crossref","unstructured":"Chiaravalloti, N.D. and DeLuca, J. (2008). Cognitive impairment in multiple sclerosis. Lancet Neurol. 7, 1139\u20131151.10.1016\/S1474-4422(08)70259-X19007738","DOI":"10.1016\/S1474-4422(08)70259-X"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_032_w2aab3b7b2b1b6b1ab1c11c32Aa","doi-asserted-by":"crossref","unstructured":"Chiaravalloti, N.D., Demaree, H., Gaudino, E.A., and DeLuca, J. (2003). Can the repetition effect maximize learning in multiple sclerosis? Clin. Rehabil. 17, 58\u201368.10.1191\/0269215503cr586oa12617380","DOI":"10.1191\/0269215503cr586oa"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_033_w2aab3b7b2b1b6b1ab1c11c33Aa","doi-asserted-by":"crossref","unstructured":"Chiaravalloti, N.D., Wylie, G., Leavitt, V., and Deluca, J. (2012). Increased cerebral activation after behavioral treatment for memory deficits in MS. J. Neurol. 259, 1337\u20131346.2223781910.1007\/s00415-011-6353-x","DOI":"10.1007\/s00415-011-6353-x"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_034_w2aab3b7b2b1b6b1ab1c11c34Aa","doi-asserted-by":"crossref","unstructured":"Chiaravalloti, N.D., Genova, H.M., and DeLuca, J. (2015). Cognitive rehabilitation in multiple sclerosis: the role of plasticity. Front. Neurol. 6, 67.25883585","DOI":"10.3389\/fneur.2015.00067"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_035_w2aab3b7b2b1b6b1ab1c11c35Aa","doi-asserted-by":"crossref","unstructured":"Chillemi, G., Scalera, C., Terranova, C., Calamuneri, A., Buccafusca, M., Dattola, V., Rizzo, V., Bruschetta, D., Girlanda, P., and Quartarone, A. (2015). Cognitive processess and cognitive reserve in multiple sclerosis. Arch. Ital. Biol. 153, 19\u201324.26441363","DOI":"10.12871\/00039829201512"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_036_w2aab3b7b2b1b6b1ab1c11c36Aa","doi-asserted-by":"crossref","unstructured":"Cinar, B.P., K\u00f6sehasano\u011fullar\u0131, G., Yigit, P., and Ozakbas, S. (2017). Cognitive dysfunction in patients with multiple sclerosis treated with first-line disease-modifying therapy: a multi-center, controlled study using the BICAMS battery. Neurol. Sci. 38, 337\u2013342.10.1007\/s10072-016-2775-727885448","DOI":"10.1007\/s10072-016-2775-7"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_037_w2aab3b7b2b1b6b1ab1c11c37Aa","doi-asserted-by":"crossref","unstructured":"Compston, A. and Coles, A. (2008). Multiple sclerosis. Lancet 372, 1502\u20131517.10.1016\/S0140-6736(08)61620-718970977","DOI":"10.1016\/S0140-6736(08)61620-7"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_038_w2aab3b7b2b1b6b1ab1c11c38Aa","doi-asserted-by":"crossref","unstructured":"Dagenais, E., Rouleau, I., Tremblay, A., Demers, M., Roger, \u00c9., Jobin, C., and Duquette, P. (2016). Role of executive functions in prospective memory in multiple sclerosis: impact of the strength of cue-action association. J. Clin. Exp. Neuropsychol. 38, 127\u2013140.10.1080\/13803395.2015.109106326588195","DOI":"10.1080\/13803395.2015.1091063"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_039_w2aab3b7b2b1b6b1ab1c11c39Aa","doi-asserted-by":"crossref","unstructured":"das Nair, R., Martin, K.J., and Lincoln, N.B. (2016). Memory rehabilitation for people with multiple sclerosis. Cochrane Database Syst. Rev. 3, CD008754.27004596","DOI":"10.1002\/14651858.CD008754.pub3"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_040_w2aab3b7b2b1b6b1ab1c11c40Aa","doi-asserted-by":"crossref","unstructured":"De Giglio, L., De Luca, F., Prosperini, L., Borriello, G., Bianchi, V., Pantano, P., and Pozzilli, C. (2015). A low-cost cognitive rehabilitation with a commercial video game improves sustained attention and executive functions in multiple sclerosis: a pilot study. Neurorehabil. Neural Repair 29, 453\u2013461.10.1177\/154596831455462325398725","DOI":"10.1177\/1545968314554623"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_041_w2aab3b7b2b1b6b1ab1c11c41Aa","doi-asserted-by":"crossref","unstructured":"Deloire, M., Ruet, A., Hamel, D., Bonnet, M., and Brochet, B. (2010). Early cognitive impairment in multiple sclerosis predicts disability outcome several years later. Mult. Scler. 16, 581\u2013587.2019457810.1177\/1352458510362819","DOI":"10.1177\/1352458510362819"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_042_w2aab3b7b2b1b6b1ab1c11c42Aa","doi-asserted-by":"crossref","unstructured":"DeLuca, G.C., Yates, R.L., Beale, H., and Morrow, S.A. (2015). Cognitive impairment in multiple sclerosis: clinical, radiologic and pathologic insights. Brain Pathol. 25, 79\u201398.10.1111\/bpa.1222025521179","DOI":"10.1111\/bpa.12220"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_043_w2aab3b7b2b1b6b1ab1c11c43Aa","doi-asserted-by":"crossref","unstructured":"DeLuca, J. (2005). Fatigue, cognition, and mental effort. In: Fatigue as a Window to the Brain. J. DeLuca, ed. (Cambridge, MA, USA: MIT Press), pp. 37\u201357.","DOI":"10.7551\/mitpress\/2967.003.0006"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_044_w2aab3b7b2b1b6b1ab1c11c44Aa","doi-asserted-by":"crossref","unstructured":"DeLuca, J., Gaudino, E.A., Diamond, B.J., Christodoulou, C., and Engel, R.A. (1998). Acquisition and storage deficits in multiple sclerosis. J. Clin. Exp. Neuropsychol. 20, 376\u2013390.10.1076\/jcen.20.3.376.8199845164","DOI":"10.1076\/jcen.20.3.376.819"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_045_w2aab3b7b2b1b6b1ab1c11c45Aa","doi-asserted-by":"crossref","unstructured":"Diker, S., Has, A.C., Kurne, A., G\u00f6\u00e7men, R., O\u011fuz, K.K., and Karabudak, R. (2016). The association of cognitive impairment with gray matter atrophy and cortical lesion load in clinically isolated syndrome. Mult. Scler. Relat. Disord. 10, 14\u201321.2791948210.1016\/j.msard.2016.08.008","DOI":"10.1016\/j.msard.2016.08.008"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_046_w2aab3b7b2b1b6b1ab1c11c46Aa","doi-asserted-by":"crossref","unstructured":"Dineen, R.A., Vilisaar, J., Hlinka, J., Bradshaw, C.M., Morgan, P.S., Constantinescu, C.S., and Auer, D.P. (2009). Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain 132, 239\u2013249.10.1093\/brain\/awn27518953055","DOI":"10.1093\/brain\/awn275"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_047_w2aab3b7b2b1b6b1ab1c11c47Aa","doi-asserted-by":"crossref","unstructured":"Drew, M., Tippett, L.J., Starkey, N.J., and Isler, R.B. (2008). Executive dysfunction and cognitive impairment in a large community-based sample with multiple sclerosis form New Zealand: a descriptive study. Arch. Clin. Neuropsychol. 23, 1\u201319.10.1016\/j.acn.2007.09.005","DOI":"10.1016\/j.acn.2007.09.005"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_048_w2aab3b7b2b1b6b1ab1c11c48Aa","doi-asserted-by":"crossref","unstructured":"Dusankova, J.B., Kalincik, T., Havrdova, E., and Benedict, R.H. (2012). Cross cultural validation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Clin. Neuropsychol. 26, 1186\u20131200.10.1080\/13854046.2012.72510123034066","DOI":"10.1080\/13854046.2012.725101"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_049_w2aab3b7b2b1b6b1ab1c11c49Aa","doi-asserted-by":"crossref","unstructured":"Edan, G., Kappos, L., Montalb\u00e1n, X., Polman, C.H., Freedman, M.S., Hartung, H.P., Miller, D., Barkhof, F., Herrmann, J., Lanius, V., et al. (2014). Long-term impact of interferon \u03b2-1b in patients with CIS: 8-year follow-up of BENEFIT. J. Neurol. Neurosurg. Psychiatry 85, 1183\u20131189.10.1136\/jnnp-2013-30622224218527","DOI":"10.1136\/jnnp-2013-306222"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_050_w2aab3b7b2b1b6b1ab1c11c50Aa","doi-asserted-by":"crossref","unstructured":"Feuillet, L., Reuter, F., Audoin, B., Malikova, I., Barrau, K., Cherif, A.A., and Pelletier, J. (2007). Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult. Scler. 13, 124\u2013127.10.1177\/135245850607119617294621","DOI":"10.1177\/1352458506071196"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_051_w2aab3b7b2b1b6b1ab1c11c51Aa","doi-asserted-by":"crossref","unstructured":"Filippi, M., Rocca, M.A., Benedict, R.H., DeLuca, J., Geurts, J.J., Rombouts, S.A., Ron, M., and Comi, G. (2010). The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology 75, 2121\u20132128.2113538710.1212\/WNL.0b013e318200d768","DOI":"10.1212\/WNL.0b013e318200d768"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_052_w2aab3b7b2b1b6b1ab1c11c52Aa","doi-asserted-by":"crossref","unstructured":"Fink, F., Rischkau, E., Butt, M., Klein, J., Eling, P., and Hildebrandt, H. (2010). Efficacy of an executive function intervention programme in MS: a placebo-controlled and pseudo-randomized trial. Mult. Scler. 16, 1148\u20131151.10.1177\/1352458510375440","DOI":"10.1177\/1352458510375440"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_053_w2aab3b7b2b1b6b1ab1c11c53Aa","doi-asserted-by":"crossref","unstructured":"Fischer, J.S., Priore, R.L., Jacobs, L.D., Cookfair, D.L., Rudick, R.A., Herndon, R.M., Richert, J.R., Salazar, A.M., Goodkin, D.E., Granger, C.V., et al. (2000). Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Ann. Neurol. 48, 885\u2013892.10.1002\/1531-8249(200012)48:6<885::AID-ANA9>3.0.CO;2-111117545","DOI":"10.1002\/1531-8249(200012)48:6<885::AID-ANA9>3.3.CO;2-T"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_054_w2aab3b7b2b1b6b1ab1c11c54Aa","doi-asserted-by":"crossref","unstructured":"Ford-Johnson, L., DeLuca, J., Zhang, J., Elovic, E., Lengenfelder, J., and Chiaravalloti, N.D. (2016). Cognitive effects of modafinil in patients with multiple sclerosis: a clinical trial. Rehabil. Psychol. 61, 82\u201391.10.1037\/a003991926654280","DOI":"10.1037\/a0039919"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_055_w2aab3b7b2b1b6b1ab1c11c55Aa","doi-asserted-by":"crossref","unstructured":"Frith, C. and Frith, U. (2005). Theory of mind. Curr. Biol. 15, R644\u2013R646.10.1016\/j.cub.2005.08.041","DOI":"10.1016\/j.cub.2005.08.041"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_056_w2aab3b7b2b1b6b1ab1c11c56Aa","doi-asserted-by":"crossref","unstructured":"Frith, C.D. and Frith, U. (2012). Mechanisms of social cognition. Annu. Rev. Psychol. 63, 287\u2013313.2183854410.1146\/annurev-psych-120710-100449","DOI":"10.1146\/annurev-psych-120710-100449"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_057_w2aab3b7b2b1b6b1ab1c11c57Aa","doi-asserted-by":"crossref","unstructured":"Gainotti, G. (2006). Measures of cognitive and emotional changes in multiple sclerosis and underlying models of brain dysfunction. J. Neurol. Sci. 245, 15\u201320.10.1016\/j.jns.2005.09.01316626747","DOI":"10.1016\/j.jns.2005.09.013"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_058_w2aab3b7b2b1b6b1ab1c11c58Aa","doi-asserted-by":"crossref","unstructured":"Geisler, M.W., Sliwinski, M., Coyle, P.K., Masur, D.M., Doscher, C., and Krupp, L.B. (1996). The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis. Arch. Neurol. 53, 185\u2013188.10.1001\/archneur.1996.005500201010218639070","DOI":"10.1001\/archneur.1996.00550020101021"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_059_w2aab3b7b2b1b6b1ab1c11c59Aa","doi-asserted-by":"crossref","unstructured":"Geurts, J.J., Calabrese, M., Fisher, E., and Rudick, R.A. (2012). Measurement and clinical effect of grey matter pathology in multiple sclerosis. Lancet Neurol. 11, 1082\u20131092.10.1016\/S1474-4422(12)70230-223153407","DOI":"10.1016\/S1474-4422(12)70230-2"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_060_w2aab3b7b2b1b6b1ab1c11c60Aa","doi-asserted-by":"crossref","unstructured":"Ghaffar, O., Reis, M., Pennell, N., O\u2018Connor, P., and Feinstein, A. (2010). APOE epsilon4 and the cognitive genetics of multiple sclerosis. Neurology 74, 1611\u20131618.2047936010.1212\/WNL.0b013e3181e074a7","DOI":"10.1212\/WNL.0b013e3181e074a7"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_061_w2aab3b7b2b1b6b1ab1c11c61Aa","doi-asserted-by":"crossref","unstructured":"Golan, D., Doniger, G.M., Wissemann, K., Zarif, M., Bumstead, B., Buhse, M., Fafard, L., Lavi, I., Wilken, J., and Gudesblatt, M. (2017). The impact of subjective cognitive fatigue and depression on cognitive function in patients with multiple sclerosis. Mult. Scler. 1, 1352458517695470.","DOI":"10.1177\/1352458517695470"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_062_w2aab3b7b2b1b6b1ab1c11c62Aa","doi-asserted-by":"crossref","unstructured":"Goretti, B., Niccolai, C., Hakiki, B., Sturchio, A., Falautano, M., Minacapelli, E., Martinelli, V., Incerti, C., Nocentini, U., Murgia, M., et al. (2014). The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population. BMC Neurol. 14, 171.10.1186\/s12883-014-0171-625204350","DOI":"10.1186\/s12883-014-0171-6"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_063_w2aab3b7b2b1b6b1ab1c11c63Aa","doi-asserted-by":"crossref","unstructured":"Goverover, Y., Chiaravalloti, N., and DeLuca, J. (2016). Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) and performance of everyday life tasks: actual reality. Mult. Scler. 22, 544\u2013550.10.1177\/135245851559363726163071","DOI":"10.1177\/1352458515593637"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_064_w2aab3b7b2b1b6b1ab1c11c64Aa","doi-asserted-by":"crossref","unstructured":"Granberg, T., Martola, J., Bergendal, G., Shams, S., Damangir, S., Aspelin, P., Fredrikson, S., and Kristoffersen-Wiberg, M. (2015). Corpus callosum atrophy is strongly associated with cognitive impairment in multiple sclerosis: results of a 17-year longitudinal study. Mult. Scler. 21, 1151\u20131158.10.1177\/135245851456092825480866","DOI":"10.1177\/1352458514560928"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_065_w2aab3b7b2b1b6b1ab1c11c65Aa","doi-asserted-by":"crossref","unstructured":"Guimar\u00e3es, J. and S\u00e1, M.J. (2012). Cognitive dysfunction in multiple sclerosis. Front. Neurol. 3, 74.22654782","DOI":"10.3389\/fneur.2012.00074"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_066_w2aab3b7b2b1b6b1ab1c11c66Aa","doi-asserted-by":"crossref","unstructured":"Hanssen, K.T., Beiske, A.G., Landr\u00f8, N.I., Hofoss, D., and Hessen, E. (2016). Cognitive rehabilitation in multiple sclerosis: a randomized controlled trial. Acta Neurol. Scand. 133, 30\u201340.10.1111\/ane.1242025952561","DOI":"10.1111\/ane.12420"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_067_w2aab3b7b2b1b6b1ab1c11c67Aa","doi-asserted-by":"crossref","unstructured":"Harel, Y., Appleboim, N., Lavie, M., and Achiron, A. (2009). Single dose of methylphenidate improves cognitive performance in multiple sclerosis patients with impaired attention process. J. Neurol. Sci. 276, 38\u201340.10.1016\/j.jns.2008.08.02518817930","DOI":"10.1016\/j.jns.2008.08.025"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_068_w2aab3b7b2b1b6b1ab1c11c68Aa","doi-asserted-by":"crossref","unstructured":"Hawellek, D.J., Hipp, J.F., Lewis, C.M., Corbetta, M., and Engel, A.K. (2011). Increased functional connectivity indicates the severity of cognitive impairment in multiple sclerosis. Proc. Natl. Acad. Sci. USA 108, 19066\u201319071.10.1073\/pnas.1110024108","DOI":"10.1073\/pnas.1110024108"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_069_w2aab3b7b2b1b6b1ab1c11c69Aa","doi-asserted-by":"crossref","unstructured":"Henry, J.D. and Beatty, W.W. (2006). Verbal fluency deficits in multiple sclerosis. Neuropsychologia 44, 1166\u20131174.10.1016\/j.neuropsychologia.2005.10.00616293271","DOI":"10.1016\/j.neuropsychologia.2005.10.006"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_070_w2aab3b7b2b1b6b1ab1c11c70Aa","unstructured":"Herndon, R.M. (2003). Multiple Sclerosis: Immunology, Pathology and Pathophysiology (New York: Demos Medical Publishing)."},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_071_w2aab3b7b2b1b6b1ab1c11c71Aa","doi-asserted-by":"crossref","unstructured":"Hollenbach, J.A. and Oksenberg, J.R. (2015). The immunogenetics of multiple sclerosis: a comprehensive review. J. Autoimmun. 64, 13\u201325.10.1016\/j.jaut.2015.06.01026142251","DOI":"10.1016\/j.jaut.2015.06.010"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_072_w2aab3b7b2b1b6b1ab1c11c72Aa","doi-asserted-by":"crossref","unstructured":"Honan, C.A., Brown, R.F., and Batchelor, J. (2015). Perceived cognitive difficulties and cognitive test performance as predictors of employment outcomes in people with multiple sclerosis. J. Int. Neuropsychol. Soc. 21, 156\u2013168.2572793010.1017\/S1355617715000053","DOI":"10.1017\/S1355617715000053"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_073_w2aab3b7b2b1b6b1ab1c11c73Aa","doi-asserted-by":"crossref","unstructured":"Hosseini, B., Flora, D.B., Banwell, B.L., and Till, C. (2014). Age of onset as a moderator of cognitive decline in pediatric-onset multiple sclerosis. J. Int. Neuropsychol. Soc. 20, 796\u2013804.2503316310.1017\/S1355617714000642","DOI":"10.1017\/S1355617714000642"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_074_w2aab3b7b2b1b6b1ab1c11c74Aa","doi-asserted-by":"crossref","unstructured":"Huolman, S., H\u00e4m\u00e4l\u00e4inen, P., Vorobyev, V., Ruutiainen, J., Parkkola, R., Laine, T., and H\u00e4m\u00e4l\u00e4inen, H. (2011). The effects of rivastigmine on processing speed and brain activation in patients with multiple sclerosis and subjective cognitive fatigue. Mult. Scler. 17, 1351\u20131361.2184669210.1177\/1352458511412061","DOI":"10.1177\/1352458511412061"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_075_w2aab3b7b2b1b6b1ab1c11c75Aa","doi-asserted-by":"crossref","unstructured":"Iaffaldano, P., Viterbo, R.G., Paolicelli, D., Lucchese, G., Portaccio, E., Goretti, B., Direnzo, V., D\u2018Onghia, M., Zoccolella, S., Amato, M.P., et al. (2012). Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study. PLoS One 7, e35843.10.1371\/journal.pone.003584322558238","DOI":"10.1371\/journal.pone.0035843"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_076_w2aab3b7b2b1b6b1ab1c11c76Aa","doi-asserted-by":"crossref","unstructured":"Iaffaldano, P., Viterbo, R.G., and Trojano, M. (2016). Natalizumab discontinuation is associated with a rebound of cognitive impairment in multiple sclerosis patients. J. Neurol. 263, 1620\u20131625.10.1007\/s00415-016-8177-127260295","DOI":"10.1007\/s00415-016-8177-1"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_077_w2aab3b7b2b1b6b1ab1c11c77Aa","doi-asserted-by":"crossref","unstructured":"Janculjak, D., Mubrin, A., Brinar, V., and Spilich, G. (2002). Changes of attention and memory in a group of patients with multiple sclerosis. Clin. Neurol. Neurosurg. 104, 221\u2013227.10.1016\/S0303-8467(02)00042-2","DOI":"10.1016\/S0303-8467(02)00042-2"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_079_w2aab3b7b2b1b6b1ab1c11c78Aa","doi-asserted-by":"crossref","unstructured":"Jonkman, L.E., Rosenthal, D.M., Sormani, M.P., Miles, L., Herbert, J., Grossman, R.I., and Inglese, M. (2015) Gray matter correlates of cognitive performance differ between relapsing-remitting and primary-progressive multiple sclerosis. PLoS One 10, e0129380.10.1371\/journal.pone.012938026485710","DOI":"10.1371\/journal.pone.0129380"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_080_w2aab3b7b2b1b6b1ab1c11c79Aa","doi-asserted-by":"crossref","unstructured":"Kappos, L., Freedman, M.S., Polman, C.H., Edan, G., Hartung, H.P., Miller, D.H., Montalb\u00e1n, X., Barkhof, F., Rad\u00fc, E.W., Metzig, C., et al. (2009). Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurol. 8, 987\u2013997.10.1016\/S1474-4422(09)70237-619748319","DOI":"10.1016\/S1474-4422(09)70237-6"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_081_w2aab3b7b2b1b6b1ab1c11c80Aa","doi-asserted-by":"crossref","unstructured":"Kappos, L., Wiendl, H., Selmaj, K., Arnold, D.L., Havrdova, E., Boyko, A., Kaufman, M., Rose, J., Greenberg, S., Sweetser, M., et al. (2015). Daclizumab HYP versus interferon beta-1a in relapsing multiple sclerosis. N. Engl. J. Med. 373, 1418\u20131428.2644472910.1056\/NEJMoa1501481","DOI":"10.1056\/NEJMoa1501481"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_082_w2aab3b7b2b1b6b1ab1c11c81Aa","doi-asserted-by":"crossref","unstructured":"Keser, Z., Hasan, K.M., Mwangi, B., Gabr, R.E., and Nelson, F.M. (2017). Diffusion tensor imaging-defined sulcal enlargement is related to cognitive impairment in multiple sclerosis. J. Neuroimaging. 27, 312\u2013317.2786254910.1111\/jon.12406","DOI":"10.1111\/jon.12406"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_083_w2aab3b7b2b1b6b1ab1c11c82Aa","doi-asserted-by":"crossref","unstructured":"Khatri, B., Barkhof, F., Comi, G., Hartung, H.P., Kappos, L., Montalban, X., Pelletier, J., Stites, T., Wu, S., Holdbrook, F., et al. (2011). Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS Study. Lancet Neurol. 10, 520\u2013529.2157159310.1016\/S1474-4422(11)70099-0","DOI":"10.1016\/S1474-4422(11)70099-0"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_084_w2aab3b7b2b1b6b1ab1c11c83Aa","doi-asserted-by":"crossref","unstructured":"Kinner, M., Hoepner, R., Klotz, P., Prehn, C., Faissner, S., Salmen, A., Linker, R.A., Gold, R., and Chan, A. (2016). Immunotherapy improves cognitive function in secondary progressive multiple sclerosis. CNS Neurosci. Ther. 22, 1019\u20131022.2773924710.1111\/cns.12652","DOI":"10.1111\/cns.12652"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_085_w2aab3b7b2b1b6b1ab1c11c84Aa","doi-asserted-by":"crossref","unstructured":"Koenig, K.A., Sakaie, K.E., Lowe, M.J., Lin, J., Stone, L., Bermel, R.A., Beall, E.B., Rao, S.M., Trapp, B.D., and Phillips, M.D. (2015). The relationship between cognitive function and high-resolution diffusion tensor MRI of the cingulum bundle in multiple sclerosis. Mult. Scler. 21, 1794\u20131801.10.1177\/135245851557698326106010","DOI":"10.1177\/1352458515576983"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_087_w2aab3b7b2b1b6b1ab1c11c85Aa","doi-asserted-by":"crossref","unstructured":"Krupp, L.B., Christodoulou, C., Melville, P., Scherl, W.F., MacAllister, W.S., and Elkins, L.E. (2004). Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology 63, 1579\u20131585.10.1212\/01.WNL.0000142989.09633.5A","DOI":"10.1212\/01.WNL.0000142989.09633.5A"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_088_w2aab3b7b2b1b6b1ab1c11c86Aa","doi-asserted-by":"crossref","unstructured":"Krupp, L.B., Christodoulou, C., Melville, P., Scherl, W.F., Pai, L.Y., Muenz, L.R., He, D., Benedict, R.H., Goodman, A., Rizvi, S., et al. (2011). Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis. Neurology 76, 1500\u20131507.10.1212\/WNL.0b013e318218107a21519001","DOI":"10.1212\/WNL.0b013e318218107a"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_089_w2aab3b7b2b1b6b1ab1c11c87Aa","doi-asserted-by":"crossref","unstructured":"Kujala, P., Portin, R., Revonsuo, A., and Ruutiainen, J. (1995). Attention related performance in two cognitively different subgroups of patients with multiple sclerosis. J. Neurol. Neurosurgery Psychiatry 59, 77\u201382.10.1136\/jnnp.59.1.77","DOI":"10.1136\/jnnp.59.1.77"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_090_w2aab3b7b2b1b6b1ab1c11c88Aa","doi-asserted-by":"crossref","unstructured":"Lacy, M., Hauser, M., Pliskin, N., Assuras, S., Valentine, M.O., and Reder, A. (2013). The effects of long-term interferon-beta-1b treatment on cognitive functioning in multiple sclerosis: a 16-year longitudinal study. Mult. Scler. 19, 1765\u20131772.2365221410.1177\/1352458513485981","DOI":"10.1177\/1352458513485981"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_091_w2aab3b7b2b1b6b1ab1c11c89Aa","doi-asserted-by":"crossref","unstructured":"Langdon, D.W., Amato, M.P., Boringa, J., Brochet, B., Foley, F., Fredrikson, S., H\u00e4m\u00e4l\u00e4inen, P., Hartung, H.P., Krupp, L., Penner, I.K., et al. (2012). Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult. Scler. 18, 891\u2013898.10.1177\/135245851143107622190573","DOI":"10.1177\/1352458511431076"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_092_w2aab3b7b2b1b6b1ab1c11c90Aa","doi-asserted-by":"crossref","unstructured":"Leclercq, E., Cabaret, M., Guilbert, A., Jougleux, C., Vermersch, P., and Moroni, C. (2014). The influence of age and illness duration on cognitive impairment in aging patients with relapsing-remitting multiple sclerosis (RR-MS). Geriatr. Psychol. Neuropsychiatr. Vieil. 12, 331\u2013338.25245320","DOI":"10.1684\/pnv.2014.0482"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_093_w2aab3b7b2b1b6b1ab1c11c91Aa","doi-asserted-by":"crossref","unstructured":"Lincoln, N.B., Dent, A., Harding, J., Weyman, N., Nicholl, C., Blumhardt, L.D., and Playford, E.D. (2002). Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 72, 93\u201398.10.1136\/jnnp.72.1.9311784832","DOI":"10.1136\/jnnp.72.1.93"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_094_w2aab3b7b2b1b6b1ab1c11c92Aa","doi-asserted-by":"crossref","unstructured":"Lopes Costa, S., Gon\u00e7alves, O.F., DeLuca, J., Chiaravalloti, N., Chakravarthi, R., and Almeida, J. (2016). The temporal dynamics of visual processing in multiple sclerosis. Appl. Neuropsychol. Adult 23, 133\u2013140.10.1080\/23279095.2015.102015726508328","DOI":"10.1080\/23279095.2015.1020157"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_095_w2aab3b7b2b1b6b1ab1c11c93Aa","doi-asserted-by":"crossref","unstructured":"Lovera, J., Bagert, B., Smoot, K., Morris, C.D., Frank, R., Bogardus, K., Wild, K., Oken, B., Whitham, R., and Bourdette, D. (2007). Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial. Mult. Scler. 13, 376\u2013385.1743990710.1177\/1352458506071213","DOI":"10.1177\/1352458506071213"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_096_w2aab3b7b2b1b6b1ab1c11c94Aa","doi-asserted-by":"crossref","unstructured":"Lovera, J.F., Frohman, E., Brown, T.R., Bandari, D., Nguyen, L., Yadav, V., Stuve, O., Karman, J., Bogardus, K., Heimburger, G., et al. (2010). Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial. Mult. Scler. 16, 715\u2013723.10.1177\/135245851036766220483885","DOI":"10.1177\/1352458510367662"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_097_w2aab3b7b2b1b6b1ab1c11c95Aa","doi-asserted-by":"crossref","unstructured":"Luerding, R., Gebel, S., Gebel, E.M., Schwab-Malek, S., and Weissert, R. (2016). Influence of formal education on cognitive reserve in patients with multiple sclerosis. Front. Neurol. 7, 46.27065941","DOI":"10.3389\/fneur.2016.00046"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_098_w2aab3b7b2b1b6b1ab1c11c96Aa","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Lapiscina, E.H., Fraga-Pumar, E., Gabilondo, I., Mart\u00ednez-Heras, E., Torres-Torres, R., Ortiz-P\u00e9rez, S., Llufriu, S., Tercero, A., Andorra, M., Roca, M.F., et al. (2014). The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS. BMC Res. Notes 7, 910.10.1186\/1756-0500-7-91025512202","DOI":"10.1186\/1756-0500-7-910"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_099_w2aab3b7b2b1b6b1ab1c11c97Aa","doi-asserted-by":"crossref","unstructured":"McCarthy, M., Beaumont, J.G., Thompson, R., and Peacock, S. (2005). Modalityspecific aspects of sustained and divided attentional performance in multiple sclerosis. Arch. Clin. Neuropsychol. 20, 705\u2013718.10.1016\/j.acn.2005.04.007","DOI":"10.1016\/j.acn.2005.04.007"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_100_w2aab3b7b2b1b6b1ab1c11c98Aa","doi-asserted-by":"crossref","unstructured":"Meijer, K.A., Cercignani, M., Muhlert, N., Sethi, V., Chard, D., Geurts, J.J., and Ciccarelli, O. (2016). Patterns of white matter damage are non-random and associated with cognitive function in secondary progressive multiple sclerosis. Neuroimage Clin. 12, 123\u2013131.10.1016\/j.nicl.2016.06.00927408797","DOI":"10.1016\/j.nicl.2016.06.009"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_101_w2aab3b7b2b1b6b1ab1c11c99Aa","doi-asserted-by":"crossref","unstructured":"Migliore, S., Ghazaryan, A., Simonelli, I., Pasqualetti, P., Landi, D., Palmieri, M.G., Moffa, F., Rinaldi, P., Vernieri, F., and Filippi, M.M. (2016). Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population. Neurol. Sci. 37, 1261\u20131270.2709505210.1007\/s10072-016-2578-x","DOI":"10.1007\/s10072-016-2578-x"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_102_w2aab3b7b2b1b6b1ab1c11d100Aa","doi-asserted-by":"crossref","unstructured":"Mitolo, M., Venneri, A., Wilkinson, I.D., and Sharrack, B. (2015). Cognitive rehabilitation in multiple sclerosis: a systematic review. J. Neurol. Sci. 354, 1\u20139.2599826110.1016\/j.jns.2015.05.004","DOI":"10.1016\/j.jns.2015.05.004"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_103_w2aab3b7b2b1b6b1ab1c11d101Aa","doi-asserted-by":"crossref","unstructured":"Mokhber, N., Azarpazhooh, A., Orouji, E., Rao, S.M., Khorram, B., Sahraian, M.A., Foroghipoor, M., Gharavi, M.M., Kakhi, S., Nikkhah, K., et al. (2014). Cognitive dysfunction in patients with multiple sclerosis treated with different types of interferon \u03b2: a randomized clinical trial. J. Neurol. Sci. 342, 16\u201320.2484132110.1016\/j.jns.2014.01.038","DOI":"10.1016\/j.jns.2014.01.038"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_104_w2aab3b7b2b1b6b1ab1c11d102Aa","unstructured":"Mori, F., Kusayanagi, H., Buttari, F., Centini, B., Monteleone, F., Nicoletti, C.G., Bernardi, G., Di Cantogno, E.V., Marciani, M.G., and Centonze, D. (2012). Early treatment with high-dose interferon \u03b2-1a reverses cognitive and cortical plasticity deficits in multiple sclerosis. Funct. Neurol. 27, 163\u2013168."},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_105_w2aab3b7b2b1b6b1ab1c11d103Aa","doi-asserted-by":"crossref","unstructured":"Moroso, A., Ruet, A., Lamargue-Hamel, D., Munsch, F., Deloire, M., Coup\u00e9, P., Ouallet, J.C., Planche, V., Moscufo, N., Meier, D.S., et al. (2017). Posterior lobules of the cerebellum and information processing speed at various stages of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 88, 146\u2013151.2778954110.1136\/jnnp-2016-313867","DOI":"10.1136\/jnnp-2016-313867"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_106_w2aab3b7b2b1b6b1ab1c11d104Aa","doi-asserted-by":"crossref","unstructured":"Morrow, S.A., Smerbeck, A., Patrick, K., Cookfair, D., Weinstock-Guttman, B., andBenedict, R.H. (2009). Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study. J. Neurol. 260, 489\u2013497.","DOI":"10.1007\/s00415-012-6663-7"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_107_w2aab3b7b2b1b6b1ab1c11d105Aa","doi-asserted-by":"crossref","unstructured":"Morrow, S.A., O\u2019Connor, P.W., Polman, C.H., Goodman, A.D., Kappos, L., Lublin, F.D., Rudick, R.A., Jurgensen, S., Paes, D., Forrestal, F., et al. (2010). Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks. Mult. Scler. 16, 1385\u20131392.10.1177\/135245851037802120739335","DOI":"10.1177\/1352458510378021"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_108_w2aab3b7b2b1b6b1ab1c11d106Aa","doi-asserted-by":"crossref","unstructured":"Motl, R.W., Sandroff, B.M., and Benedict, R.H. (2011). Cognitive dysfunction and multiple sclerosis: developing a rationale for considering the efficacy of exercise training. Mult. Scler. 17, 1034\u20131040.10.1177\/135245851140961221685231","DOI":"10.1177\/1352458511409612"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_109_w2aab3b7b2b1b6b1ab1c11d107Aa","doi-asserted-by":"crossref","unstructured":"Nocentini, U., Pasqualetti, P., Bonavita, S., Buccafusca, M., De Caro, M.F., Farina, D., Girlanda, P., Le Pira, F., Lugaresi, A., Quattrone, A., et al. (2006). Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. Mult. Scler. 12, 77\u201387.1645972310.1191\/135248506ms1227oa","DOI":"10.1191\/135248506ms1227oa"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_110_w2aab3b7b2b1b6b1ab1c11d108Aa","doi-asserted-by":"crossref","unstructured":"Nourbakhsh, B., Nunan-Saah, J., Maghzi, A.H., Julian, L.J., Spain, R., Jin, C., Lazar, A., Pelletier, D., and Waubant E. (2016). Longitudinal associations between MRI and cognitive changes in very early MS. Mult. Scler. Relat. Disord. 5, 47\u201352.10.1016\/j.msard.2015.10.010","DOI":"10.1016\/j.msard.2015.10.010"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_111_w2aab3b7b2b1b6b1ab1c11d109Aa","doi-asserted-by":"crossref","unstructured":"Nunnari, D., De Cola, M.C., D\u2019Aleo, G., Rifici, C., Russo, M., Sessa, E., Bramanti, P., and Marino, S. (2015) Impact of depression, fatigue, and global measure of cortical volume on cognitive impairment in multiple sclerosis. Biomed. Res. Int. 2015, 519785.25861633","DOI":"10.1155\/2015\/519785"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_112_w2aab3b7b2b1b6b1ab1c11d110Aa","doi-asserted-by":"crossref","unstructured":"Oken, B.S., Kishiyama, S., Zajdel, D., Bourdette, D., Carlsen, J., Haas, M., Hugos, C., Kraemer, D.F., Lawrence, J., and Mass, M. (2004). Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology 62, 2058\u20132064.1518461410.1212\/01.WNL.0000129534.88602.5C","DOI":"10.1212\/01.WNL.0000129534.88602.5C"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_113_w2aab3b7b2b1b6b1ab1c11d111Aa","doi-asserted-by":"crossref","unstructured":"Papathanasiou, A., Messinis, L., Zampakis, P., Panagiotakis, G., Gourzis, P., Georgiou, V., and Papathanasopoulos, P. (2015) Thalamic atrophy predicts cognitive impairment in relapsing remitting multiple sclerosis. Effect on instrumental activities of daily living and employment status. J. Neurol. Sci. 358, 236\u2013242.10.1016\/j.jns.2015.09.00126359854","DOI":"10.1016\/j.jns.2015.09.001"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_114_w2aab3b7b2b1b6b1ab1c11d112Aa","doi-asserted-by":"crossref","unstructured":"Patanella, A.K., Zinno, M., Quaranta, D., Nociti, V., Frisullo, G., Gainotti, G., Tonali, P.A., Batocchi, A.P., and Marra, C. (2010). Correlations between peripheral blood mononuclear cell production of BDNF, TNF-\u03b1, IL-6, IL-10 and cognitive performances in multiple sclerosis patients. J. Neurosci. Res. 88, 1106\u20131112.19885866","DOI":"10.1002\/jnr.22276"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_115_w2aab3b7b2b1b6b1ab1c11d113Aa","doi-asserted-by":"crossref","unstructured":"Patten, S.B., Beck, C.A., Williams, J.V., Barbui, C., and Metz, L.M. (2003). Major depression in multiple sclerosis: a population-based perspective. Neurology 61, 1524\u20131527.1466303610.1212\/01.WNL.0000095964.34294.B4","DOI":"10.1212\/01.WNL.0000095964.34294.B4"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_116_w2aab3b7b2b1b6b1ab1c11d114Aa","doi-asserted-by":"crossref","unstructured":"Patti, F., Morra, V.B., Amato, M.P., Trojano, M., Bastianello, S., Tola, M.R., Cottone, S., Plant, A., Picconi, O., and COGIMUS Study Group. (2013). Subcutaneous interferon \u03b2-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study. PLoS One 8, e74111.10.1371\/journal.pone.007411124137499","DOI":"10.1371\/journal.pone.0074111"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_117_w2aab3b7b2b1b6b1ab1c11d115Aa","doi-asserted-by":"crossref","unstructured":"Pelosi, L., Geesken, J.M., Holly, M., Hayward, M., and Blumhardt, L.D. (1997). Working memory impairment in early multiple-sclerosis. Evidence from an event-related potential study of patients with clinically isolated myelopathy. Brain 120, 2039\u20132058.10.1093\/brain\/120.11.20399397020","DOI":"10.1093\/brain\/120.11.2039"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_118_w2aab3b7b2b1b6b1ab1c11d116Aa","doi-asserted-by":"crossref","unstructured":"Penner, I.K., Opwis, K., and Kappos, L. (2007). Relation between functional brain imaging, cognitive impairment and cognitive rehabilitation in patients with multiple sclerosis. J. Neurol. 254(Suppl. 2), II53\u2013II57.","DOI":"10.1007\/s00415-007-2013-6"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_119_w2aab3b7b2b1b6b1ab1c11d117Aa","doi-asserted-by":"crossref","unstructured":"Penner, I.K., Raselli, C., St\u00f6cklin, M., Opwis, K., Kappos, L., and Calabrese, P. (2009). The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult. Scler. 15, 1509\u20131517.10.1177\/135245850934851919995840","DOI":"10.1177\/1352458509348519"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_120_w2aab3b7b2b1b6b1ab1c11d118Aa","doi-asserted-by":"crossref","unstructured":"Penner, I.K., Stemper, B., Calabrese, P., Freedman, M.S., Polman, C.H., Edan, G., Hartung, H.P., Miller, D.H., Montalb\u00e1n, X., Barkhof, F., et al. (2012). Effects of interferon \u03b2-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis. Mult. Scler. 18, 1466\u20131471.10.1177\/135245851244243822492127","DOI":"10.1177\/1352458512442438"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_121_w2aab3b7b2b1b6b1ab1c11d119Aa","doi-asserted-by":"crossref","unstructured":"Peyro Saint Paul, L., Creveuil, C., Heinzlef, O., De Seze, J., Vermersch, P., Castelnovo, G., Cabre, P., Debouverie, M., Brochet, B., Dupuy, B., et al. (2016). Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: a randomized, placebo-controlled study. J. Neurol. Sci. 363, 69\u201376.2700022410.1016\/j.jns.2016.02.012","DOI":"10.1016\/j.jns.2016.02.012"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_122_w2aab3b7b2b1b6b1ab1c11d120Aa","doi-asserted-by":"crossref","unstructured":"Peyser, J.M., Rao, S.M., LaRocca, N.G., and Kaplan, E. (1990). Guidelines for neuropsychological research in multiple sclerosis. Arch. Neurol. 47, 94\u201397.10.1001\/archneur.1990.005300101200302403789","DOI":"10.1001\/archneur.1990.00530010120030"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_123_w2aab3b7b2b1b6b1ab1c11d121Aa","doi-asserted-by":"crossref","unstructured":"Piras, M.R., Magnano, I., Canu, E.D., Paulus, K.S., Satta, W.M., Soddu, A., Conti, M., Achene, A., Solinas, G., and Aiello, I. (2003). Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings. J. Neurol. Neurosurg. Psychiatry 74, 878\u2013885.1281077110.1136\/jnnp.74.7.878","DOI":"10.1136\/jnnp.74.7.878"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_124_w2aab3b7b2b1b6b1ab1c11d122Aa","doi-asserted-by":"crossref","unstructured":"Planche, V., Gibelin, M., Cregut, D., Pereira, B., and Clavelou, P. (2016). Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis. Eur. J. Neurol. 23, 282\u2013289.10.1111\/ene.12715","DOI":"10.1111\/ene.12715"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_125_w2aab3b7b2b1b6b1ab1c11d123Aa","doi-asserted-by":"crossref","unstructured":"Polychroniadou, E., Bakirtzis, C., Langdon, D., Lagoudaki, R., Kesidou, E., Theotokis, P., Tsalikakis, D., Poulatsidou, K., Kyriazis, O., Boziki, M., et al. (2016). Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in Greek population with multiple sclerosis. Mult. Scler. Relat. Disord. 9, 68\u201372.10.1016\/j.msard.2016.06.01127645348","DOI":"10.1016\/j.msard.2016.06.011"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_126_w2aab3b7b2b1b6b1ab1c11d124Aa","doi-asserted-by":"crossref","unstructured":"Portaccio, E., Stromillo, M.L., Goretti, B., Hakiki, B., Giorgio, A., Rossi, F., De Leucio, A., De Stefano, N., and Amato, M.P. (2013). Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis \u2013 a prospective, non-randomized pilot study. Eur. J. Neurol. 20, 986\u2013990.10.1111\/j.1468-1331.2012.03882.x23057658","DOI":"10.1111\/j.1468-1331.2012.03882.x"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_127_w2aab3b7b2b1b6b1ab1c11d125Aa","doi-asserted-by":"crossref","unstructured":"Potagas, C., Giogkaraki, E., Koutsis, G., Mandellos, D., Tsirempolou, E., Sfagos, C., and Vassilopoulos, D. (2008). Cognitive impairment in different MS subtypes and clinically isolated syndromes. J. Neurol. Sci. 267, 100\u2013106.10.1016\/j.jns.2007.10.00217997417","DOI":"10.1016\/j.jns.2007.10.002"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_128_w2aab3b7b2b1b6b1ab1c11d126Aa","doi-asserted-by":"crossref","unstructured":"P\u00f6ttgen, J., Dziobek, I., Reh, S., Heesen, C., and Gold, S.M. (2013). Impaired social cognition in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 84, 523\u2013528.2331562110.1136\/jnnp-2012-304157","DOI":"10.1136\/jnnp-2012-304157"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_129_w2aab3b7b2b1b6b1ab1c11d127Aa","doi-asserted-by":"crossref","unstructured":"Pozzilli, C., Passafiume, D., Bernardi, S., Pantano, P., Incoccia, C., Bastianello, S., Bozzao, L., Lenzi, G.L., and Fieschi, C. (1991). SPECT, MRI and cognitive functions in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 54, 110\u2013115.10.1136\/jnnp.54.2.1102019835","DOI":"10.1136\/jnnp.54.2.110"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_130_w2aab3b7b2b1b6b1ab1c11d128Aa","doi-asserted-by":"crossref","unstructured":"Preziosa, P., Rocca, M.A., Pagani, E., Stromillo, M.L., Enzinger, C., Gallo, A. Hulst, H.E., Atzori, M., Pareto, D., Riccitelli, G.C., et al. (2016). Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: a multicenter study. Hum. Brain Mapp. 37, 1627\u20131644.2683396910.1002\/hbm.23125","DOI":"10.1002\/hbm.23125"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_131_w2aab3b7b2b1b6b1ab1c11d129Aa","doi-asserted-by":"crossref","unstructured":"Rao, S.M. (1986). Neuropsychology of multiple sclerosis: a critical review. J. Clin. Exp. Neuropsychol. 8, 503\u2013542.380525010.1080\/01688638608405173","DOI":"10.1080\/01688638608405173"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_132_w2aab3b7b2b1b6b1ab1c11d130Aa","unstructured":"Rao, S.M. and Cognitive Function Study Group, National Multiple Sclerosis Society. (1990). A manual for the Brief Repeatable Battery of Neuropsychological Tests in multiple sclerosis. (New York: National Multiple Sclerosis Society)."},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_133_w2aab3b7b2b1b6b1ab1c11d131Aa","doi-asserted-by":"crossref","unstructured":"Rao, S.M., Leo, G.J., and St. Aubin-Faubert, P. (1989). On the nature of memory disturbance in multiple sclerosis. J. Clin. Exp. Neuropsychol. 11: 699\u2013712.280865910.1080\/01688638908400926","DOI":"10.1080\/01688638908400926"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_134_w2aab3b7b2b1b6b1ab1c11d132Aa","doi-asserted-by":"crossref","unstructured":"Rao, S., Leo, G., Bernardin, L., and Unverzagt, F. (1991). Cognitive dysfunction in multiple sclerosis: frequency, patterns, and predictions. Neurology 41, 685\u2013691.10.1212\/WNL.41.5.685","DOI":"10.1212\/WNL.41.5.685"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_135_w2aab3b7b2b1b6b1ab1c11d133Aa","doi-asserted-by":"crossref","unstructured":"Rocca, M.A., Valsasina, P., Hulst, H.E., Abdel-Aziz, K., Enzinger, C., Gallo, A., Pareto, D., Riccitelli, G., Muhlert, N., Ciccarelli, O., et al. (2014). Functional correlates of cognitive dysfunction in multiple sclerosis: a multicenter fMRI study. Hum. Brain Mapp. 35, 5799\u20135814.10.1002\/hbm.2258625045065","DOI":"10.1002\/hbm.22586"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_136_w2aab3b7b2b1b6b1ab1c11d134Aa","doi-asserted-by":"crossref","unstructured":"Rocca, M.A., Amato, M.P., De Stefano, N., Enzinger, C., Geurts, J.J., Penner, I.K., Rovira, A., Sumowski, J.F., Valsasina, P., Filippi, M., et al. (2015). Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol. 14, 302\u2013317.2566290010.1016\/S1474-4422(14)70250-9","DOI":"10.1016\/S1474-4422(14)70250-9"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_137_w2aab3b7b2b1b6b1ab1c11d135Aa","doi-asserted-by":"crossref","unstructured":"Rojas, J.I., Patrucco, L., Miguez, J., and Cristiano, E. (2016). Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact. Arq. Neuropsiquiatr. 74, 235\u2013243.2705085410.1590\/0004-282X20160015","DOI":"10.1590\/0004-282X20160015"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_138_w2aab3b7b2b1b6b1ab1c11d136Aa","doi-asserted-by":"crossref","unstructured":"Roosendaal, S.D., Geurts, J.J., Vrenken, H., Hulst, H.E., Cover, K.S., Castelijns, J.A., Pouwels, P.J., and Barkhof, F. (2009). Regional DTI differences in multiple sclerosis patients. Neuroimage 44, 1397\u20131403.1902707610.1016\/j.neuroimage.2008.10.026","DOI":"10.1016\/j.neuroimage.2008.10.026"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_139_w2aab3b7b2b1b6b1ab1c11d137Aa","doi-asserted-by":"crossref","unstructured":"Roosendaal, S.D., Moraal, B., Vrenken, H., Castelijns, J.A., Pouwels, P.J., Barkhof, F., and Geurts, J.J. (2008). In vivo MR imaging of hippocampal lesions in multiple sclerosis. J. Magn. Reson. Imaging. 27, 726\u2013731.10.1002\/jmri.2129418302199","DOI":"10.1002\/jmri.21294"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_140_w2aab3b7b2b1b6b1ab1c11d138Aa","doi-asserted-by":"crossref","unstructured":"Rosti-Otaj\u00e4rvi, E.M. and H\u00e4m\u00e4l\u00e4inen, P.I. (2014). Neuropsychological rehabilitation for multiple sclerosis. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD009131.","DOI":"10.1002\/14651858.CD009131.pub3"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_141_w2aab3b7b2b1b6b1ab1c11d139Aa","doi-asserted-by":"crossref","unstructured":"Ruet, A., Deloire, M., Charr\u00e9-Morin, J., Hamel, D., and Brochet, B. (2013a). Cognitive impairment differs between primary progressive and relapsing-remitting MS. Neurology 80, 1501\u20131508.10.1212\/WNL.0b013e31828cf82f","DOI":"10.1212\/WNL.0b013e31828cf82f"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_142_w2aab3b7b2b1b6b1ab1c11d140Aa","doi-asserted-by":"crossref","unstructured":"Ruet, A., Deloire, M., Hamel, D., Ouallet, J.C., Petry, K., and Brochet, B. (2013b). Cognitive impairment, health related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study. J. Neurol. 260, 776\u2013784.10.1007\/s00415-012-6705-1","DOI":"10.1007\/s00415-012-6705-1"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_143_w2aab3b7b2b1b6b1ab1c11d141Aa","doi-asserted-by":"crossref","unstructured":"Sacco, R., Bisecco, A., Corbo, D., Della Corte, M., d\u2019Ambrosio, A., Docimo, R., Gallo, A., Esposito, F., Esposito, S., Cirillo, M., et al. (2015). Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus. J. Neurol. 262, 1691\u20131697.10.1007\/s00415-015-7763-y25957638","DOI":"10.1007\/s00415-015-7763-y"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_144_w2aab3b7b2b1b6b1ab1c11d142Aa","doi-asserted-by":"crossref","unstructured":"Sailer, M., Heinze, H.J., Schoenfeld, M.A., Hauser, U., and Smid, H.G. (2000). Amantadine influences cognitive processing in patients with multiple sclerosis. Pharmacopsychiatry 33, 28\u201337.10.1055\/s-2000-796610721881","DOI":"10.1055\/s-2000-7966"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_145_w2aab3b7b2b1b6b1ab1c11d143Aa","doi-asserted-by":"crossref","unstructured":"Sandi, D., Rudisch, T., F\u00fcvesi, J., Fricska-Nagy, Z., Huszka, H., Biernacki, T., Langdon, D.W., Langane, \u00c9., V\u00e9csei, L., and Bencsik, K. (2015). The Hungarian validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery and the correlation of cognitive impairment with fatigue and quality of life. Mult. Scler. Relat. Disord. 4, 499\u2013504.2659065410.1016\/j.msard.2015.07.006","DOI":"10.1016\/j.msard.2015.07.006"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_146_w2aab3b7b2b1b6b1ab1c11d144Aa","doi-asserted-by":"crossref","unstructured":"Sandroff, B.M., Johnson, C.L., and Motl, R.W. (2017). Exercise training effects on memory and hippocampal viscoelasticity in multiple sclerosis: a novel application of magnetic resonance elastography. Neuroradiology 59, 61\u201367.10.1007\/s00234-016-1767-x27889837","DOI":"10.1007\/s00234-016-1767-x"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_147_w2aab3b7b2b1b6b1ab1c11d145Aa","doi-asserted-by":"crossref","unstructured":"Santos, T., Pinheiro, J., and Barros, P. (2015). Cognitive Impairment in Multiple Sclerosis. Eur. Neurol. Rev. 10, 157\u2013163.10.17925\/ENR.2015.10.02.157","DOI":"10.17925\/ENR.2015.10.02.157"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_148_w2aab3b7b2b1b6b1ab1c11d146Aa","doi-asserted-by":"crossref","unstructured":"Schoonheim, M.M., Geurts, J.J., and Barkhof, F. (2010). The limits of functional reorganization in multiple sclerosis. Neurology 74, 1246\u20131247.10.1212\/WNL.0b013e3181db995720404304","DOI":"10.1212\/WNL.0b013e3181db9957"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_149_w2aab3b7b2b1b6b1ab1c11d147Aa","doi-asserted-by":"crossref","unstructured":"Schoonheim, M.M., Geurts, J.J., Landi, D., Douw, L., van der Meer, M.L., Vrenken, H., Polman, C.H., Barkhof, F., and Stam, C.J. (2013). Functional connectivity changes in multiple sclerosis patients: a graph analytical study of MEG resting state data. Hum. Brain Mapp. 34, 52\u201361.2195410610.1002\/hbm.21424","DOI":"10.1002\/hbm.21424"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_150_w2aab3b7b2b1b6b1ab1c11d148Aa","doi-asserted-by":"crossref","unstructured":"Schoonheim, M.M., Meijer, K.A., and Geurts, J.J. (2015). Network collapse and cognitive impairment in multiple sclerosis. Front. Neurol. 6, 82.25926813","DOI":"10.3389\/fneur.2015.00082"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_151_w2aab3b7b2b1b6b1ab1c11d149Aa","doi-asserted-by":"crossref","unstructured":"Schoonheim, M.M., Vigeveno, R.M., Rueda Lopes, F.C., Pouwels, P.J., Polman, C.H., Barkhof, F., and Geurts, J.J. (2014). Sex-specific extent and severity of white matter damage in multiple sclerosis: implications for cognitive decline. Hum. Brain Mapp. 35, 2348\u20132358.2398291810.1002\/hbm.22332","DOI":"10.1002\/hbm.22332"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_152_w2aab3b7b2b1b6b1ab1c11d150Aa","doi-asserted-by":"crossref","unstructured":"Schwid, S.R., Goodman, A.D., Weinstein, A., McDermott, M.P., Johnson, K.P., and Copaxone Study Group. (2007). Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial. J. Neurol. Sci. 255, 57\u201363.10.1016\/j.jns.2007.01.070","DOI":"10.1016\/j.jns.2007.01.070"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_153_w2aab3b7b2b1b6b1ab1c11d151Aa","doi-asserted-by":"crossref","unstructured":"Shatil, E., Metzer, A., Horvitz, O., and Miller, A. (2010). Home-based personalized cognitive training in MS patients: a study of adherence and cognitive performance. NeuroRehabil. 26, 143\u2013153.","DOI":"10.3233\/NRE-2010-0546"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_154_w2aab3b7b2b1b6b1ab1c11d152Aa","doi-asserted-by":"crossref","unstructured":"Shi, J., Tu, J.L., Gale, S.D., Baxter, L., Vollmer, T.L., Campagnolo, D.I., Tyry, T.M., Zhuang, Y., and Kuniyoshi, S.M. (2011). APOE \u03b54 is associated with exacerbation of cognitive decline in patients with multiple sclerosis. Cogn. Behav. Neurol. 24, 128\u2013133.2194598410.1097\/WNN.0b013e31823380b5","DOI":"10.1097\/WNN.0b013e31823380b5"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_155_w2aab3b7b2b1b6b1ab1c11d153Aa","unstructured":"Shkil\u2018niuk, G.G., Il\u2018ves, A.G., Prakhova, L.N., Kataeva, G.V., and Stolirov, I.D. (2013). PET-patterns of cognitive impairment in patients with multiple sclerosis. Zh. Nevrol. Psikhiatr. Im. S S Korsakova 113, 53\u201356.23528594"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_156_w2aab3b7b2b1b6b1ab1c11d154Aa","doi-asserted-by":"crossref","unstructured":"Siegert, R.J. and Abernethy, D.A. (2005). Depression in multiple sclerosis: a review. J. Neurol. Neurosurg. Psychiatry. 76, 469\u2013475.1577443010.1136\/jnnp.2004.054635","DOI":"10.1136\/jnnp.2004.054635"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_157_w2aab3b7b2b1b6b1ab1c11d155Aa","doi-asserted-by":"crossref","unstructured":"Staples, D. and Lincoln, N.B. (1979). Intellectual impairment in multiple sclerosis and its relation to functional abilities. Rheumatol. Rehabil. 18, 153\u2013160.10.1093\/rheumatology\/18.3.153493802","DOI":"10.1093\/rheumatology\/18.3.153"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_158_w2aab3b7b2b1b6b1ab1c11d156Aa","doi-asserted-by":"crossref","unstructured":"Strober, L., Englert, J., Munschauer, F., Weinstock-Guttman, B., Rao, S., and Benedict, R.H. (2009). Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS. Mult. Scler. 15, 1077\u20131084.1955631110.1177\/1352458509106615","DOI":"10.1177\/1352458509106615"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_159_w2aab3b7b2b1b6b1ab1c11d157Aa","doi-asserted-by":"crossref","unstructured":"Sumowski, J.F. and Leavitt, V.M. (2013). Cognitive reserve in multiple sclerosis. Mult. Scler. 19, 1122\u20131127.10.1177\/135245851349883423897894","DOI":"10.1177\/1352458513498834"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_160_w2aab3b7b2b1b6b1ab1c11d158Aa","doi-asserted-by":"crossref","unstructured":"Sundgren, M., Piehl, F., Wahlin, \u00c5., and Brismar, T. (2016). Cognitive function did not improve after initiation of natalizumab treatment in relapsing-remitting multiple sclerosis. A prospective one-year dual control group study. Mult. Scler. Relat. Disord. 10, 36\u201343.10.1016\/j.msard.2016.08.01127919496","DOI":"10.1016\/j.msard.2016.08.011"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_161_w2aab3b7b2b1b6b1ab1c11d159Aa","doi-asserted-by":"crossref","unstructured":"Thornton, A.E., Raz, N., and Tucke, K.A. (2002). Memory in multiple sclerosis: contextual encoding deficits. J. Int. Neuropsychol. 8, 395\u2013409.10.1017\/S1355617702813200","DOI":"10.1017\/S1355617702813200"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_162_w2aab3b7b2b1b6b1ab1c11d160Aa","doi-asserted-by":"crossref","unstructured":"Triche, E.W., Ruiz, J.A., Olson, K.M., and Lo, A.C. (2016). Changes in cognitive processing speed, mood, and fatigue in an observational study of persons with multiple sclerosis treated with dalfampridine-ER. Clin. Neuropharmacol. 39, 73\u201380.10.1097\/WNF.0000000000000130","DOI":"10.1097\/WNF.0000000000000130"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_163_w2aab3b7b2b1b6b1ab1c11d161Aa","doi-asserted-by":"crossref","unstructured":"van Munster, C.E., Jonkman, L.E., Weinstein, H.C., Uitdehaag, B.M., and Geurts, J.J. (2015). Gray matter damage in multiple sclerosis: impact on clinical symptoms. Neuroscience 303, 446\u2013461.2616450010.1016\/j.neuroscience.2015.07.006","DOI":"10.1016\/j.neuroscience.2015.07.006"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_164_w2aab3b7b2b1b6b1ab1c11d162Aa","doi-asserted-by":"crossref","unstructured":"Van Schependom, J., Gielen, J., Laton, J., D\u2019hooghe, M.B., De Keyser, J., and Nagels, G. (2014). Graph theoretical analysis indicates cognitive impairment in MS stems from neural disconnection. Neuroimage Clin. 4, 403\u2013410.10.1016\/j.nicl.2014.01.01224567912","DOI":"10.1016\/j.nicl.2014.01.012"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_165_w2aab3b7b2b1b6b1ab1c11d163Aa","doi-asserted-by":"crossref","unstructured":"Van Schependom, J., D\u2018hooghe, M.B., Cleynhens, K., D\u2019hooge, M., Haelewyck, M.C., De Keyser, J., and Nagels, G. (2015). Reduced information processing speed as primum movens for cognitive decline in MS. Mult. Scler. 21, 83\u201391.2501314910.1177\/1352458514537012","DOI":"10.1177\/1352458514537012"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_166_w2aab3b7b2b1b6b1ab1c11d164Aa","doi-asserted-by":"crossref","unstructured":"Vleugels, L., Lafosse, C., van Nunen, A., Nachtergaele, S., Ketelaer, P., Charlier, M., and Vandenbussche, E. (2000). Visuospatial impairment in multiple sclerosis patients diagnosed with neuropsychological tasks. Mult. Scler. 6, 241\u2013254.10.1191\/135245800678827879","DOI":"10.1177\/135245850000600406"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_167_w2aab3b7b2b1b6b1ab1c11d165Aa","doi-asserted-by":"crossref","unstructured":"Vogt, A., Kappos, L., Calabrese, P., Stocklin, M., Gschwind, L., Opwis, K., and Penner, I.K. (2009). Working memory training in patients with multiple sclerosis \u2013 comparison of two different training schedules. Restor. Neurol. Neurosci. 27, 225\u2013235.19531877","DOI":"10.3233\/RNN-2009-0473"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_168_w2aab3b7b2b1b6b1ab1c11d166Aa","doi-asserted-by":"crossref","unstructured":"Waxman, S.G. (1982). Membranes, myelin, and the pathophysiology of multiple sclerosis. N. Engl. J. Med. 306, 1529\u20131533.704327110.1056\/NEJM198206243062505","DOI":"10.1056\/NEJM198206243062505"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_169_w2aab3b7b2b1b6b1ab1c11d167Aa","doi-asserted-by":"crossref","unstructured":"Wegener, S., Marx, I., and Zettl, U.K. (2013). Cognitive deficits and dementia in patients with multiple sclerosis: status quo and open questions. Fortschr. Neurol. Psychiatr. 81, 639\u2013647.24194057","DOI":"10.1055\/s-0033-1355497"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_170_w2aab3b7b2b1b6b1ab1c11d168Aa","doi-asserted-by":"crossref","unstructured":"Weinstein, A., Schwid, S.I.L., Schiffer, R.B., McDermott, M.P., Giang, D.W., and Goodman, A.D. (1999). Neuropsychologic status in multiple sclerosis after treatment with Glatiramer. Arch. Neurol. 56, 319\u2013324.10.1001\/archneur.56.3.31910190822","DOI":"10.1001\/archneur.56.3.319"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_171_w2aab3b7b2b1b6b1ab1c11d169Aa","doi-asserted-by":"crossref","unstructured":"Weinstock-Guttman, B., Benedict, R.H., Tama\u00f1o-Blanco, M., Ramasamy, D.P., Stosic, M., Polito, J., Zivadinov, R., and Ramanathan, M. (2011). The rs2030324 SNP of brain-derived neurotrophic factor (BDNF) is associated with visual cognitive processing in multiple sclerosis. Pathophysiology 18, 43\u201352.2054704310.1016\/j.pathophys.2010.04.005","DOI":"10.1016\/j.pathophys.2010.04.005"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_172_w2aab3b7b2b1b6b1ab1c11d170Aa","doi-asserted-by":"crossref","unstructured":"Weinstock-Guttman, B., Galetta, S.L., Giovannoni, G., Havrdova, E., Hutchinson, M., Kappos, L., O\u2019Connor, P.W., Phillips, J.T., Polman, C., Stuart, W.H., et al. (2012). Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS. J. Neurol. 259, 898\u2013905.2200887310.1007\/s00415-011-6275-7","DOI":"10.1007\/s00415-011-6275-7"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_173_w2aab3b7b2b1b6b1ab1c11d171Aa","doi-asserted-by":"crossref","unstructured":"Wilken, J., Kane, R.L., Sullivan., C.L., Gudesblatt, M., Lucas, S., Fallis, R., You, X., and Foulds, P. (2013). Changes in fatigue and cognition in patients with relapsing forms of multiple sclerosis treated with natalizumab: the ENER-G study. Int. J. MS Care. 15, 120\u2013128.10.7224\/1537-2073.2012-04324453774","DOI":"10.7224\/1537-2073.2012-043"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_174_w2aab3b7b2b1b6b1ab1c11d172Aa","doi-asserted-by":"crossref","unstructured":"Winkelmann, A., Engel, C., Apel, A., and Zettl, U.K. (2007). Cognitive impairment in multiple sclerosis. J. Neurol. 254(Suppl. 2), II35\u2013II42.","DOI":"10.1007\/s00415-007-2010-9"},{"key":"2024080906554937378_j_revneuro-2017-0011_ref_175_w2aab3b7b2b1b6b1ab1c11d173Aa","doi-asserted-by":"crossref","unstructured":"Zipoli, V., Goretti, B., Hakiki, B., Siracusa, G., Sorbi, S., Portaccio, E., and Amato, M.P. (2010). Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. Mult. Scler. 16, 62\u201367.10.1177\/135245850935031119995837","DOI":"10.1177\/1352458509350311"}],"container-title":["Reviews in the Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/revneuro.2017.28.issue-8\/revneuro-2017-0011\/revneuro-2017-0011.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2017-0011\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2017-0011\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T06:56:59Z","timestamp":1723186619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2017-0011\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,8]]},"references-count":173,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,8]]},"published-print":{"date-parts":[[2017,11,27]]}},"alternative-id":["10.1515\/revneuro-2017-0011"],"URL":"https:\/\/doi.org\/10.1515\/revneuro-2017-0011","relation":{},"ISSN":["2191-0200","0334-1763"],"issn-type":[{"value":"2191-0200","type":"electronic"},{"value":"0334-1763","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8,8]]}}}